| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.6 |